Interviews - Clinical trials and in-house drug development are expensive and time-consuming aspects of the biotechnology industry, but are nevertheless fixtures of standard business development. SciClone Pharmaceuticals … Continue Reading
Interviews - Abaxis (NASDAQ:ABAX) CEO Clint Severson discusses opportunities for growth and comments on the Federal Trade Commission’s (FTC) investigation into Idexx Laboratories’ (NASDAQ:IDXX) non-compete agreement with … Continue Reading
Interviews - Discussing Rigel Pharmaceutical’s (NASDAQ:RIGL) immunomodulatory Rheumatoid Arthritis (RA) treatment, CEO Jim Gower says it has the potential to replace TNF inhibitors as the standard-of-care, with … Continue Reading
Interviews - Ron Squarer, Chief Executive of Array BioPharma (NASDAQ: ARRY), sits down with PropThink.com to discuss the company’s pipeline, positioning, and commercialization strategies. Squarer says robust … Continue Reading
You're all done! We've sent you a confirmation email that includes a verification link. To access the page you're interested in, check your email inbox(including spam folder) and click the verification link.